Enthusiasm for Transplant-Free Strategies for Low-Risk Relapsed Hodgkin Lymphoma

(MedPage Today) -- Non-transplant salvage therapy for low-risk relapsed/refractory pediatric classical Hodgkin lymphoma (cHL) had high rates of progression-free (PFS) and overall survival (OS) at 3-5 years, three separate studies showed.
A multicenter...